Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

Also called NCT01801007

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 145 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01801007
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01801007. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2018-01 (actual). Results posted on 2020-10-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms
Acronym
FRED
Condition
Intracranial Aneurysms
Intervention (Device)
Flow Re-Direction Endoluminal Device (FRED)
Lead sponsor
Microvention-Terumo, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01801007
Content hash
c2433cb98783b6bb5d22973448b78deac27e093293ffa1ac7b0cbbd761140fc4